Khalid Lana, Al-Balushi Said, Manoj Nandita, Rather Sufyan, Johnson Heather, Strauss Laura, Dutta Sourabh, Mukerji Amit
Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Am J Perinatol. 2024 May;41(S 01):e664-e670. doi: 10.1055/a-1925-8643. Epub 2022 Aug 17.
This study aimed to evaluate whether the initial pressure level on high continuous positive airway pressure (CPAP; ≥9 cm HO), in relation to preextubation mean airway pressure (Paw), influences short-term clinical outcomes in preterm neonates.
In this retrospective cohort study, preterm neonates <29 weeks' gestational age (GA) extubated from mean Paw ≥9 cm HO and to high CPAP (≥9 cm HO) were classified into "higher level CPAP" (2-3 cm HO higher than preextubation Paw) and "equivalent CPAP" (-1 to +1 cm HO in relation to preextubation Paw). Only the first eligible extubation per infant was analyzed. The primary outcome was failure within ≤7 days of extubation, defined as any one or more of (1) need for reintubation, (2) escalation to an alternate noninvasive respiratory support mode, or (3) use of CPAP >preextubation Paw + 3 cm HO. Secondary outcomes included individual components of the primary outcome, along with other clinical and safety outcomes.
Over a 10-year period (Jan 2011-Dec 2020), 175 infants were extubated from mean Paw >9 cm HO to high CPAP pressures. Twenty-seven patients (median GA = 24.7, [interquartile range (IQR)]: (24.0-26.4) weeks and chronological age = 31, IQR: [21-40] days) were classified into the "higher level CPAP" group while 148 infants (median GA = 25.4, IQR: [24.6-26.6] weeks and chronological age = 26, IQR: [10-39] days) comprised the "equivalent CPAP" group. There was no difference in the primary outcome (44 vs. 51%; = 0.51), including postadjustment for confounders (adjusted OR [aOR] = 0.47 [95% confidence interval (CI): 0.17-1.29; = 0.14]). However, reintubation risk within 7 days was lower with higher level CPAP (7 vs. 37%; < 0.01), including postadjustment (aOR = 0.07; 95% CI: 0.02-0.35; < 0.01).
In this cohort, use of initial distending CPAP pressures 2 to 3 cm HO higher than preextubation Paw did not alter the primary outcome of failure but did lower the risk of reintubation. The latter is an interesting hypothesis-generating finding that requires further confirmation.
· Use of high CPAP pressures (≥9 cm H2O) is gradually increasing in the care of preterm neonates.. · This study compares higher level versus equivalent CPAP in relation to preextubation Paw.. · The findings demonstrate no difference in failure as defined with use of higher level CPAP pressures..
本研究旨在评估高持续气道正压通气(CPAP;≥9 cm H₂O)初始压力水平相对于拔管前平均气道压(Paw)对早产儿短期临床结局的影响。
在这项回顾性队列研究中,胎龄(GA)<29周、从平均Paw≥9 cm H₂O拔管并接受高CPAP(≥9 cm H₂O)治疗的早产儿被分为“较高水平CPAP组”(比拔管前Paw高2 - 3 cm H₂O)和“等效CPAP组”(相对于拔管前Paw为 - 1至 + 1 cm H₂O)。仅分析每个婴儿的首次符合条件的拔管情况。主要结局是拔管后≤7天内失败,定义为以下任何一种或多种情况:(1)需要重新插管;(2)升级为替代的无创呼吸支持模式;或(3)使用的CPAP高于拔管前Paw + 3 cm H₂O。次要结局包括主要结局的各个组成部分,以及其他临床和安全性结局。
在10年期间(2011年1月至2020年12月),175例婴儿从平均Paw>9 cm H₂O拔管至高CPAP压力。27例患者(GA中位数 = 24.7,[四分位间距(IQR)]:(24.0 - 26.4)周,实足年龄 = 31,IQR:[21 - 40]天)被分为“较高水平CPAP组”,而148例婴儿(GA中位数 = 25.4,IQR:[24.6 - 26.6]周,实足年龄 = 26,IQR:[10 - 39]天)组成“等效CPAP组”。主要结局无差异(44%对51%;P = 0.51),包括对混杂因素进行调整后(调整后比值比[aOR] = 0.47 [95%置信区间(CI):0.17 - 1.29;P = 0.14])。然而,较高水平CPAP组7天内重新插管风险较低(7%对37%;P < 0.01),包括调整后(aOR = 0.07;95% CI:0.02 - 0.35;P < 0.01)。
在该队列中,使用比拔管前Paw高2至3 cm H₂O的初始扩张性CPAP压力未改变失败的主要结局,但降低了重新插管的风险。后者是一个有趣的产生假设的发现,需要进一步证实。
· 在早产儿护理中,高CPAP压力(≥9 cm H₂O)的使用正在逐渐增加。· 本研究比较了相对于拔管前Paw的较高水平CPAP与等效CPAP。· 研究结果表明,使用较高水平CPAP压力定义的失败情况无差异。